Allergic diseases are considered by the World Health Organization as a major global hygiene problem. Epinephrine is the first choice for clinical rescue of anaphylactic shock, because the role of epinephrine is antagonistic to the symptoms of anaphylactic shock. At present, the incidence of allergies is increasing worldwide, which has promoted the demand for the epinephrine market. However, owing to the potential side effects (dizziness, shortness of breath and severe headache) of epinephrine therapy, doctors recommend or dispense other alternative pharmacotherapy against allergic reactions, which poses a challenge to the growth of the epinephrine market. The high cost of epinephrine products such as epinephrine auto-injector also hinders the development of the market to a certain extent.
Get FREE Sample of Epinephrine Market Report at:
https://www.globalmarketmonitor.com/request.php?type=3&rid=589155
The Major Players Profiled in This Report Include:
Mylan Inc
Sanofi SA
Impax
ALK Abello
Lincoln Medical Ltd
AMPHASTAR
In August 2019, Windgap Medical announced the establishment of a strategic partnership with ALK-Abelló to commercialize its epinephrine auto-injector to achieve the goal of timely treatment of anaphylactic shock. The epinephrine auto-injector issued by Windgap Medical has the characteristics of portability, temperature stability, and usability.
The Type and Application Analysis:
On the basis of type, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into:
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Others
On the basis of application, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each application/end users, primarily divided into:
Anaphylaxis
Others
To Identify the Key Trends in the Industry, Click on the Link Below:
https://www.globalmarketmonitor.com/reports/589155-epinephrine-market-report.html
Full Table of Content
Epinephrine Report Table of Content:
Chapter 1 Report Overview
Chapter 2 Market Trends and Competitive Landscape
Chapter 3 Segmentation of Epinephrine Market by Types
Chapter 4 Segmentation of Epinephrine Market by End-Users
Chapter 5 Market Analysis by Major Regions
Chapter 6 Product Commodity of Epinephrine Market in Major Countries
Chapter 7 North America Epinephrine Landscape Analysis
Chapter 8 Europe Epinephrine Landscape Analysis
Chapter 9 Asia Pacific Epinephrine Landscape Analysis
Chapter 10 Latin America, Middle East & Africa Epinephrine Landscape Analysis
Chapter 11 Major Players Profile
11.1 Mylan Inc
11.1.1 Mylan Inc Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Sanofi SA
11.2.1 Sanofi SA Profile and Recent Development
11.2.2 Market Performance
11.2.3 Product and Service Introduction
11.3 Impax
11.3.1 Impax Company Profile and Recent Development
11.3.2 Market Performance
11.3.3 Product and Service Introduction
…
Chapter 12 Data Source and Research Methodology
The List of Tables and Figures
Avail a FREE Sample to Know More About the Complete Report:
https://www.globalmarketmonitor.com/request.php?type=3&rid=589155
Available Customizations - Market Monitor offers customizations according to the company’s specific needs.
Key Questions Answered by This Report:
What is the size and CAGR of the Epinephrine Market?
What are the key driving factors of the most profitable regional market?
Which are the leading companies in the global market?
How will the Epinephrine Market advance in the coming years?
What are the main strategies adopted in the global market?
Which region may hit the highest market share in the coming era?
What trends, challenges, and barriers will impact the development and sizing of the Epinephrine Market?
Contact Info:
Name: Quella
Email: Send Email
Organization: Market Monitor
Address: One Pierrepont Plaza, 14th Floor, 300 Cadman Plaza W,Brooklyn, NY 11201, USA
Phone: + 1 (347) 467 7721
Website: https://www.globalmarketmonitor.com/
Release ID: 88968332